New Insights into Antimicrobial Discovery
A special issue of Antibiotics (ISSN 2079-6382).
Deadline for manuscript submissions: 30 September 2024 | Viewed by 7806
Special Issue Editors
Interests: peptides; antimicrobials
Special Issues, Collections and Topics in MDPI journals
Interests: peptides; microbial membranes; microbial drugs
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Antibiotics have revolutionized modern medicine, making it possible to treat otherwise deadly bacterial infections. Misuse of antibiotics has allowed the selection of resistant strains that do not respond to conventional treatments. Antibiotic resistance is a leading cause of morbidity and mortality, causing millions of deaths worldwide each year. To this end, the scientific community is conducting continuous research to discover new antibacterial agents with alternative mechanisms of action and pharmacological targets. This Special Issue covers all aspects of antimicrobial discovery, including nanomaterials, natural and synthetic compounds, repurposed drugs, and modifications of existing drugs for the treatment of multidrug-resistant infections. We invite researchers to contribute with original research and review articles.
Dr. Veronica Folliero
Dr. Gianluigi Franci
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- antimicrobial discovery
- multidrug resistance
- infectious agents
- chemotherapy
Planned Papers
The below list represents only planned manuscripts. Some of these manuscripts have not been received by the Editorial Office yet. Papers submitted to MDPI journals are subject to peer-review.
Title: Repurposing the antibacterial activity of chemioterapeutic drug Teniposide against Staphiloccocus epidermidis nosocomial infection
Authors: Veronica Folliero
Affiliation: Department of Experimental Medicine, University of Campania "Luigi Vanvitelli", Naples, Italy
Abstract: Drug repurposing is attracting considerable interest due to reduced costs and development times. The present study reports the antibacterial activity of the antitumor drug teniposide, against Staphylococcus epidermidis (S. epidermidis), the main causative agent of nosocomial and transplant-related infections. The cytotoxicity was evaluated by a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay and a hemolysis assay, on immortalized human keratinocyte cells (HaCaT) and human erythrocytes, respectively. After 20 h of drug exposure, the 50% cytotoxic and hemolytic concentrations (CC50 and EC50) were 25.24 and 57.30 μg/mL, respectively. The antibacterial potential was determined via disc diffusion, broth microdilution, LIVE/DEAD, time killing methods, scanning electron microscope (SEM) and fluorescence microscope observations, against S. epidermidis ATCC 12228 and 10 clinical isolates. The drug induced a growth inhibitory area of 22 mm and the 90% Minimum Inhibitory Concentration (MIC90) was 6.25 μg/mL, exhibiting bactericidal action. The treatment resulted in deformities in the cell morphology and revealed damage to the cell membrane, resulting in alterations of the selective permeability of the cell membrane. The drug action on biofilm biomass was investigated using crystal violet (CV) and MTT tests. Teniposide affected biofilm viability in a dose-dependent manner by inducing matrix inhibition of 41% at a concentration of 3.12 μg/mL. Overall, this study could promote the teniposide reuses as a therapeutic agent to counteract S. epidermidis infections.
Title: Magnetic nanoparticles: synthesis, characterization, and antibacterial potential
Authors: Veronica Folliero
Affiliation: Department of Experimental Medicine, University of Campania "Luigi Vanvitelli", Naples, Italy
Abstract: Multidrug-resistant (MDR) bacteria are becoming a serious threat to global health requiring immediate action. The rapid emergence of resistant strains and the limited development of new antibacterial agents limit the therapeutic options available to tackle antibiotic-resistant infections. Therefore, the scientific community conducts ongoing research to identify new antibacterial agents with innovative modes of action and alternative drug targets. In this scenario the antimicrobial properties of different nanomaterials have been studied including those of magnetic nanoparticles (MNPs). MNs are a class of nanoparticles, characterized by a central magnetic core and coating which provides specific properties and functions. These nanostructures have attracted considerable attention due to their simple synthesis, low toxicity, biocompatibility, high functionalization capacity, directed and broad-spectrum antibacterial activity. To deploy the development of NMs with next generation antibacterial potential is essential to know the recent evidence on synthesis, characterization techniques, antibacterial activity, and related mechanisms of action. This review highlights recent progress in synthetic methods, characterization, and antibacterial potentials and antibiofilm on the most bacterial pathogens that arouse greater concern in hospital and community setting.